Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2)
Abstract:A strain of Streptomyces lividans, TK24, was found to produce a pigmented antibiotic, actinorhodin, although S. lividans normally does not produce this antibiotic. Genetic analyses revealed that a streptomycin-resistant mutation str-6 in strain TK24 is responsible for induction of antibiotic synthesis. DNA sequencing showed that str-6 is a point mutation in the rpsL gene encoding ribosomal protein S12, changing Lys-88 to Glu. Gene replacement experiments with the Lys883Glu str allele demonstrated unambiguously… Show more
“…MYM‐TAP liquid medium (with 400 μL of trace element solution44 added per 200 mL of medium added after autoclaving) was used to grow Streptomyces strains for venemycin production and for RNA isolation from S. coelicolor M1825. For the halogenation studies we used Minimal Medium (MM)44 supplemented with NaCl or NaBr (0.5 g L −1 ), and modified versions of R3 medium45 consisting of glucose (10 g L −1 ), yeast extract (5 g L −1 ), casamino acids (100 mg L −1 ), proline (3 g L −1 ), MgSO 4
⋅ 7 H 2 O (10 g L −1 ), CaSO 4
⋅ 2 H 2 O (4 g L −1 ), K 2 SO 4 (200 mg L −1 ), KH 2 PO 4 (50 mg L −1 ), TES [ N ‐tris(hydroxymethyl)methyl‐2‐aminoethanesulfonic acid, 5.6 g L −1 ], trace elements (as described for R2YE medium44) and NaCl or NaBr or both (1 g L −1 ); the media were adjusted to pH 7.2 with NaOH and autoclaved. Streptomyces liquid cultures were performed in medium (50 mL) in 250 mL flasks containing stainless steel springs to promote dispersed growth with at least two replicates.…”
Comparative transcriptional profiling of a ΔbldM mutant of Streptomyces venezuelae with its unmodified progenitor revealed that the expression of a cryptic biosynthetic gene cluster containing both type I and type III polyketide synthase genes is activated in the mutant. The 29.5 kb gene cluster, which was predicted to encode an unusual biaryl metabolite, which we named venemycin, and potentially halogenated derivatives, contains 16 genes including one—vemR—that encodes a transcriptional activator of the large ATP‐binding LuxR‐like (LAL) family. Constitutive expression of vemR in the ΔbldM mutant led to the production of sufficient venemycin for structural characterisation, confirming its unusual biaryl structure. Co‐expression of the venemycin biosynthetic gene cluster and vemR in the heterologous host Streptomyces coelicolor also resulted in venemycin production. Although the gene cluster encodes two halogenases and a flavin reductase, constitutive expression of all three genes led to the accumulation only of a monohalogenated venemycin derivative, both in the native producer and the heterologous host. A competition experiment in which equimolar quantities of sodium chloride and sodium bromide were fed to the venemycin‐producing strains resulted in the preferential incorporation of bromine, thus suggesting that bromide is the preferred substrate for one or both halogenases.
“…MYM‐TAP liquid medium (with 400 μL of trace element solution44 added per 200 mL of medium added after autoclaving) was used to grow Streptomyces strains for venemycin production and for RNA isolation from S. coelicolor M1825. For the halogenation studies we used Minimal Medium (MM)44 supplemented with NaCl or NaBr (0.5 g L −1 ), and modified versions of R3 medium45 consisting of glucose (10 g L −1 ), yeast extract (5 g L −1 ), casamino acids (100 mg L −1 ), proline (3 g L −1 ), MgSO 4
⋅ 7 H 2 O (10 g L −1 ), CaSO 4
⋅ 2 H 2 O (4 g L −1 ), K 2 SO 4 (200 mg L −1 ), KH 2 PO 4 (50 mg L −1 ), TES [ N ‐tris(hydroxymethyl)methyl‐2‐aminoethanesulfonic acid, 5.6 g L −1 ], trace elements (as described for R2YE medium44) and NaCl or NaBr or both (1 g L −1 ); the media were adjusted to pH 7.2 with NaOH and autoclaved. Streptomyces liquid cultures were performed in medium (50 mL) in 250 mL flasks containing stainless steel springs to promote dispersed growth with at least two replicates.…”
Comparative transcriptional profiling of a ΔbldM mutant of Streptomyces venezuelae with its unmodified progenitor revealed that the expression of a cryptic biosynthetic gene cluster containing both type I and type III polyketide synthase genes is activated in the mutant. The 29.5 kb gene cluster, which was predicted to encode an unusual biaryl metabolite, which we named venemycin, and potentially halogenated derivatives, contains 16 genes including one—vemR—that encodes a transcriptional activator of the large ATP‐binding LuxR‐like (LAL) family. Constitutive expression of vemR in the ΔbldM mutant led to the production of sufficient venemycin for structural characterisation, confirming its unusual biaryl structure. Co‐expression of the venemycin biosynthetic gene cluster and vemR in the heterologous host Streptomyces coelicolor also resulted in venemycin production. Although the gene cluster encodes two halogenases and a flavin reductase, constitutive expression of all three genes led to the accumulation only of a monohalogenated venemycin derivative, both in the native producer and the heterologous host. A competition experiment in which equimolar quantities of sodium chloride and sodium bromide were fed to the venemycin‐producing strains resulted in the preferential incorporation of bromine, thus suggesting that bromide is the preferred substrate for one or both halogenases.
“…Here we focus on the original studies that provided the impetus for the field as well as a molecular rationale for ribosome engineering. As alluded to above, wt S. lividans TK21 normally does not produce Act, even though it contains a complete act biosynthetic gene cluster (Shima et al 1996). The original study by Ochi and colleagues investigated how the streptomycinresistant S. lividans strain TK24 produced abundant quantities of Act (Fig.…”
Section: Motivationmentioning
confidence: 99%
“…The inventors of the method were inspired by the observation that a mutated, streptomycin-resistant strain of Streptomyces lividans produced the blue pigment actinorhodin (Act, Fig. 1, 2), whereas the parent strain, from which the mutant was derived, did not (Shima et al 1996). They mapped the mutation to a ribosomal protein and showed that only the mutant ribosome led to activation of the silent Act gene cluster (act), thus demonstrating translational control in Act biosynthesis.…”
One sentence summary: Microbial secondary metabolites represent a significant source of potential drug leads; however, the majority of the corresponding biosynthetic genes are not expressed under normal laboratory conditions. In this review, we assess the capacity of exogenous small molecules, especially antibiotics, to activate these silent gene clusters. Editor: Aimee Shen
ABSTRACTNatural products have traditionally served as a dominant source of therapeutic agents. They are produced by dedicated biosynthetic gene clusters that assemble complex, bioactive molecules from simple precursors. Recent genome sequencing efforts coupled with advances in bioinformatics indicate that the majority of biosynthetic gene clusters are not expressed under normal laboratory conditions. Termed 'silent' or 'cryptic', these gene clusters represent a treasure trove for discovery of novel small molecules, their regulatory circuits and their biosynthetic pathways. In this review, we assess the capacity of exogenous small molecules in activating silent secondary metabolite gene clusters. Several approaches that have been developed are presented, including coculture techniques, ribosome engineering, chromatin remodeling and high-throughput elicitor screens. The rationale, applications and mechanisms attendant to each are discussed. Some general conclusions can be drawn from our analysis: exogenous small molecules comprise a productive avenue for the discovery of cryptic metabolites. Specifically, growth-inhibitory molecules, in some cases clinically used antibiotics, serve as effective inducers of silent biosynthetic gene clusters, suggesting that old antibiotics may be used to find new ones. The involvement of natural antibiotics in modulating secondary metabolism at subinhibitory concentrations suggests that they represent part of the microbial vocabulary through which inter-and intraspecies interactions are mediated.
“…Working with the genera Streptomyces and Bacillus, the correlation between the stringent response and antibiotic production has been established. In the absence of a functional relA or rplK gene, antibiotic production by these organisms is remarkably reduced or lost (11)(12)(13)(14). Therefore, the initiation of antibiotic production is considered to be positively regulated by the stringent response (15-18), * This work was supported by a grant from the Organized Research Combination System of the Science and Technology Agency of Japan.…”
We found that a polycistronic operon (ywfBCDEFG) and a monocistronic gene (ywfH) are required for the biosynthesis of bacilysin in Bacillus subtilis. The disruption of these genes by plasmid integration caused loss of the ability to produce bacilysin, accompanied by a lack of bacilysin synthetase activity in the crude extract. We investigated the regulatory mechanism for bacilysin biosynthesis using the transcriptional lacZ fusion system. The transcription of these genes was found to be induced at the transition from exponential to stationary phase. Induction of transcription was accelerated by depleting a required amino acid, which was done by transferring the wild-type (rel ؉ ) cells to an amino acidlimited medium. In contrast, no enhancement of the gene expression was detected in relA mutant cells. In wild-type (rel ؉ ) cells, a forced reduction of intracellular GTP, brought about by addition of decoyinine, which is a GMP synthetase inhibitor, enhanced the expression of both the ywfBCDEFG operon and the ywfH gene, resulting in a 2.5-fold increase in bacilysin production. Disruption of the codY gene, which regulates stationary phase genes by detecting the level of GTP, also induced transcription of these genes. In contrast, the expression of ywfBCDEFG in relA cells was not activated either by decoyinine addition or codY disruption, although the expression of ywfH was induced. Moreover, the codY disruption resulted in an increase of bacilysin production only in rel ؉ cells. These results indicate that guanosine 5-diphosphate 3-diphosphate (ppGpp) plays a crucial role in transcription of the ywfBCDEFG operon and that the transcription of these genes are dependent upon the level of intracellular GTP which is transmitted as a signal via the CodY-mediated repression system. We propose that, unlike antibiotic production in Streptomyces spp., bacilysin production in B. subtilis is controlled by a dual regulation system composed of the guanine nucleotides ppGpp and GTP.The stringent response is one of the most important adaptations, by which bacteria have to survive in a nutrient limited environment. This response leads to the repression of stable RNA synthesis (rRNA and tRNA) and gene expression for various translational factors and ribosomal proteins. The stringent response also activates the expression of certain genes, including the amino acids biosynthesis genes. Numerous studies have indicated that the stringent response depends on a transient increase of the hyperphosphorelated guanosine nucleotides, guanosine 5Ј-diphosphate 3Ј-diphosphate (ppGpp), 1 in response to the binding of uncharged tRNA to the ribosomal A site (1). Mutant cells that are unable to repress stable RNA synthesis under depleted amino acid conditions have been termed "relaxed." In many cases, these mutations are found in the relA gene, which encodes the ppGpp synthetase, or the relC (ϭ rplK) gene, which codes for the ribosomal protein L11. These relaxed (rel) mutants are unable to initiate ribosome-mediated synthesis of ppGpp (2-5). Therefore...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.